Do You Still Have A Reason To Buy Windtree Therapeutics Inc (NASDAQ: WINT) After A -18.93% Drop In The Last Week?
During the recent session, Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares were 1.46 million, with the beta value of the company hitting 0.54. The company’s market